0811 PDev QTs

Product Development

Aug. 11 Quick Takes: BMS hits, Genentech misses; plus JW-Lyell, CStone, Big Health

Aug 12, 2020 | 3:10 AM GMT

Opdivo clears Phase III hurdles in gastric, esophageal cancers

Opdivo nivolumab from Bristol Myers Squibb Co. (NYSE:BMY) plus chemotherapy led to a survival benefit compared with chemotherapy alone in

Read the full 446 word article

How to gain access

Continue reading with a
two-week free trial.